AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Combining the ladder with index funds adds diversification and steadier cash flow, helping manage sequence of return risk over retirement.
28,657 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Netflix reports strong cash generation as Disney funds parks and legacy assets with heavy capex, spotlighting two dis...
Regulators miss GENIUS Act's one-year deadline for final stablecoin rules, while the 2027 effective date stays in pla...
Amazon unveils a sweeping $200 billion capex plan focused on AWS and AI infra, prompting investor debate on the compa...
As 2026 unfolds, AT&T and Verizon compete for income and growth. This analysis weighs dividend safety, leverage, and ...
CF Industries climbs as global nitrogen supply tightens and European disruptions spill over into North American marke...
Balance Homes unveils a refreshed co-ownership program featuring fee rebates, HUD-certified counseling, and ongoing c...
PI tumbled again as conference buzz fades and the project presses ahead with roadmap milestones. Analysts frame it as...
Title insurance premium volume surged nearly 14% in 2025, driven by stronger mortgage activity and ongoing demand for...
Hotter weather is pushing up electricity bills this summer, with analysts warning rate pressures may persist through ...
American Airlines is pausing six domestic routes this summer amid spike in jet fuel costs tied to Middle East tension...
Five former Ethereum Foundation researchers launch Ethlabs, a nonprofit R&D lab backed by BitMine, Sharplink, and Lub...